FindTrial
Sign In

Comparison of intravenous alfentanil and intravenous oxycodone in patient-controlled analgesia after laparoscopic cholecystectomy

Comparison of intravenous alfentanil and intravenous oxycodone in patient-controlled analgesia after laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001962
Enrollment
90
Registered
2016-07-05
Start date
2014-10-22
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hallym University Medical Center- Chuncheon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Of patients who underwent laparoscopic cholecystectomy targeting 90 people belonging to ASA(American society of anesthesiologyists) physical status classification class I or II. Between the ages of 18-70, both men and ladies were included.

Exclusion criteria

Exclusion criteria: Patients who used preoperative periodically acetaminophen or non-steroidal anti-inflammatory drugs or opioids, patients who could not express Numerical rating scale (NRS), patients who had abnormal liver and kidney function and pregnant patients were excluded.

Design outcomes

Primary

MeasureTime frame
Cumulative PCA(Patient controlled analgesia ) dose—

Secondary

MeasureTime frame
Visual analogue scale;sedation scale;satisfaction;side effect—

Countries

Korea, Republic of

Contacts

Public ContactYoung Suk Kwon

Hallym University Medical Center- Chuncheon

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 2, 2026